Chronic Refractory Cough Clinical Trial
Official title:
A Comprehensive Evaluation of the Impact of ATP on Laryngeal Symptoms, Hypersensitivity and Function - an Observational Controlled Study
OBJECTIVES - To deliver a comprehensive model of laryngeal assessment, evaluating both the sensory and motor components of upper airway control and to relate this to symptom disturbance. - Determine if laryngeal control is altered by coughing and the impact of repeated coughing on overall laryngeal control and relaxation to its baseline state. - Evaluate if cell damage and tissue inflammation (including exposure to ATP) modulates laryngeal hypersensitivity and function, by using a comprehensive array of test modalities. AIM To utilise state-of-the-art comprehensive assessment tools to evaluate laryngeal hypersensitivity and function in a cohort of individuals with chronic refractory cough and control subjects. The test modalities utilise direct stimulation of the laryngeal adductor reflex, measurement of laryngeal EMG and assessment of functional laryngeal response to an inhalational challenge with laryngoscopic techniques. HYPOTHESIS Physiological markers of laryngeal hypersensitivity and dysfunction are highly prevalent in patients with chronic refractory cough and manifestations are driven by ATP stimulation. OUTCOME MEASURES Measurements of laryngeal symptomatology will be measured over a run-in period and during challenge testing. Laryngeal relaxation will be studied using our novel tracking software capability, combining endoscopic imaging and physiological measurements of diaphragm activation.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01703923 -
An Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough
|
Phase 2 | |
| Completed |
NCT02993822 -
A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough
|
Phase 2 | |
| Terminated |
NCT03979638 -
A Dose Escalation Study of BLU-5937 in Unexplained or Refractory Chronic Cough
|
Phase 2 |